Pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018, Suven Pharmaceuticals has informed that it enclosed the Confirmation Certificates issued by KFin Technologies, Registrar and Share Transfer Agents of the Company, for the quarter ended June 30, 2024.
The above information is a part of company’s filings submitted to BSE.